Implementation of WFB Protocol in Cruise Industry - THOR Meeting, Bergen June 22nd 2016
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Implementation of WFB Protocol in Cruise Industry THOR Meeting, Bergen June 22nd 2016 Steve Williams, RN, CEN, CRFN, Director, Fleet Medical Operations Royal Caribbean Cruises Ltd. June 2008 – March 2016
Royal Caribbean Cruises Ltd., ÷ 22 million people will take a cruise in 2016 ÷ 42 cruise ships, visiting 350 ports in 150 countries. ÷ 5 million guests in 2015. ÷ 40,000 crew, 86 physicians, 152 nurses.
Cruise Medicine Context HSevere hemorrhage at sea is a challenging problem. H3 G’s of bleeding; GI, GU, GYN H Storing O Negative blood is not practical. H Safe blood not readily available, universally. H Plasma expanders of limited value. H Blood substitutes are not ready for patient use. H NSAID’s, ASA and anti-coagulants seem to be making severe GI bleeding more frequent. H Use of on board blood donors is a solution. H Possibly combined with anti-fibrinolytic agents.
Royal Caribbean Cruises Ltd - Blood Transfusion Protocol for Shipboard Management of Catastrophic, Non-Compressible Hemorrhage Patient presents with active; non-compressible bleeding: > than 4 hours will elapse till transfer to appropriate shoreside medical facility Hb < 10.0 grms/d/l Hemodynamically Stable Hemodynamically Unstable INITIATE: INITIATE: ICU level monitoring ICU level monitoring IV fluid to maintain MAP> 75 mmHg 2 x large bore IV's with IV fluid to maintain MAP > 75 mmHg (Permissive Hypotension) Alert Captain 4 hrly CBC/FBC/INR / Ionized Calcium Develops Call Med Ops Hotline Hemodynamic Alert Captain 2 hrly CBC/FBC/INR/Lactate / Ionized Calcium Instability Consider Tranexamic Acid (TXA) (Note 2) Administer Tranexamic Acid (TXA) (see Note 2 below) Consider Vitamin K if on warfarin Administer Vitamin K if on warfarin Complete Eldon card screening of patient Complete Eldon card screening of patient If later than 17.00 hrs local time call for Call for donors (see Note 3 below) blood donors (see Note 1 below) Screen donors and immediately administer first unit of Routine disembark to shoreside hospital at Group O negative fresh whole blood (FWB) next port/avoid helicopter use st RE-ASSESS AFTER 1 UNIT OF FWB If still Bleeding and/or Hemodynamically Unstable Continue ICU level monitoring Routine Administer further two units of Group O negative FWB as rapidly as patient Medevac condition can tolerate Evaluate urgent MEDEVAC options with Captain/MED OPS/Notify CareTeam Avoid Risk of helicopter transport acceptable -prefer disembark in port Helicopter Send 4th unit with patient to run during MEDEVAC process Urgent Medevac Risk of Helicopter Acceptable Medical disembark to hospital with: Note on use of Calcium Chloride Endoscopy/general surgical capability ICU level care If serum ionized Calcium is < than 4.2 mg/dl then consider administering IV Availability of screened, cross matched blood Calcium Chloride 10mls of 10% solution Notify MedOps/CareTeam of receiving hospital over 30 minutes Note 1 Note 2 Note 3 Consideration should be A loading dose of Tranexamic Acid Compatible Donor Request Hierarchy given to ensuring that (Cyklokapron) should be mixed 1 gram in 1. Sexual partners identified Group O 100 ccs of 0.9% normal saline and administered 2. Male guests with blood donor cards negative or O positive over 10 minutes. (no faster than 100mgs/min) 3. Male guests without blood donor cards donors can be contacted If a maintenance infusion is required a further 4. Female donors with blood donor cards should they be required 1.0 gram is diluted in 100 ccs of 0.9% normal 5. Medical team members to report to medical saline and administered over 4 hours. 6. Crew center to donate blood, without the need for Use of Tranexamic Acid in stable patient Note: blood donated by genetically related family members increases ship-wide public address requires risk/benefit analysis, i.e. risk of risk of Graft vs Host Disease. Female donors increase risk of announcements after continuing bleeding vs inducing thrombotic Transfusion Related Acute Lung Injury (TRALI). Only take one unit 21.00 hrs local time. event. from each donor, after ensuring that the donor is not already anemic.
RCCL Clinical guidance ÷ Tranfuse to hemodynamic parameters – not Hb. ÷ Reverse anti-coagulants if possible. ÷ Consider anti-fibrinolytics. ÷ Do not over-resuscitate with fluid. ÷ Concept of “permissive hypotension”. ÷ Avoid helicopter transport if possible. ÷ Transfer to tertiary center, able to treat.
Seven year experience with shipboard FWB transfusion at RCCL ÷ Patients transfused: 73 ÷ Guests: 67 Crew: 6 ÷ Hemaglobin range: 3.4 – 10.6 grm/dl ÷ Mean Hb on presentation: 6.31 grm/dl ÷ Units given per patient range: 1 – 6 units ÷ Deaths: 6 ÷ Lost to follow up: 4 ÷ Sero-conversion at follow-up: 0 ÷ Adverse incidents: 2 (Allergic RXN) ÷ Causes: GI, GU, GYN
Training for Transfusion ÷ Heavy focus on training shipboard medical teams. ÷ Goal is annual training for all. ÷ IACSM in September/Shipboard Training. ÷ Provide summary/overview of the biology. ÷ Focus on practical skills. ÷ Critical to provide 24 hour clinical support. ÷ Clinical audit of every case/lessons learned.
RCCL Staff Survey – February 2016 ÷ Used SurveyMonkey and emailed. ÷ Covered a range of staff service 0 – 15 years. ÷ Sent to 250 current physicians and nurses. ÷ 90% response rate… ÷ 224 replied 93 physicians and 131 nurses.
Have Long Have You Been Qualified ?
Please Describe Your Clinical Background
How Long Have You Worked for RCCL ?
How many FWB transfusions have you been involved with?
Do you feel you have been adequately trained and prepared to participate in the transfusion process?
Do you feel the risk of fresh whole blood transfusion at seas is worth the benefit of lives saved?
Case Study: Mr Richard Kearns ÷ 76 year old male with prior Hx of GI bleed.. Same place !!! ÷ Wife is ICU nurse. ÷ Takes Plavix for ACS/Stent, & Lopressor for HTN ÷ Presented with active bleed and initial Hb was 12.2 grms/dl ÷ Given total of 4 units on board.
Clinical Summary B/P Pulse Hb HCT Platelets Rx 19.05 100/60 73 12.2 38.0 241K TXA 20.00 93/62 70 9.9 31.7 265K Fluid 20.30 83/60 72 9.6 31.0 250K PPI 21.00 80/62 100 LOC Blood 22.00 100/62 75 Blood 00.15 108/57 70 10.0 32.3 196K Blood 05.00 104/60 79 7.4 30.7 169K Blood
Mr Kearns presents to medical facility at 19.00 hrs 1.28.2013 01/28/2013 1900 (ship �me) – Mr. Kearns at Medical Facility 01/29/2013 0656 – Evacua�on from Vessel
Closest hospital with emergency gastroscopy: Hospiten Cancun
Oasis of the Seas Patient ÷ 66 year old German female presented with active upper GI bleed. ÷ BP 60/40, P. 120, pale, clammy, shocked, GCS 12 ÷ Initial Hb 7.3 grms/dl ÷ Closest land 246 nm or 13 hours full speed ÷ Given 5 units of blood and 2 grams of TXA ÷ Discharged after 8 days admission to hospital in Malaga, Spain, Final DX: Bleeding oesphagel varices
Conclusions ÷ WFB transfusion is a useful option for cruise ships. ÷ No hemolytic transfusion RXN using un-titred FWB ÷ Over 7 years, >60 lives have been saved where MEDEVAC was not an option. ÷ Annual training and recurrent training for staff is critical. ÷ Clinical audit and patient follow up is important. ÷ Proposal in 2016 to expand to all cruise ships on voyages > 3 sea days.
Acknowledgements ÷ Anne Bile RN, Manager, Clinical Training, RCCL ÷ Monica Wuerth, EMT CARE Team, RCCL AND of course, RCCL Shipboard medical teams
Thank you for your time…. Contact Information: Steve Williams, RN, CEN, CFRN Team Commander Florida Advanced Surgical & Transport Team State Medical Response System, State of Florida, Bureau of Emergency Response Email: command@fast-team.us Cell: 305 970 3005
You can also read